Cleared Traditional

Panther Stereotactic (K193459) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K193459 · Prowess, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2020
Decision
133d
Days
Class 2
Risk

K193459 is an FDA 510(k) clearance for the Panther Stereotactic. Classified as System, Planning, Radiation Therapy Treatment (product code MUJ), Class II - Special Controls.

Submitted by Prowess, Inc. (Concord, US). The FDA issued a Cleared decision on April 27, 2020 after a review of 133 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Prowess, Inc. devices

Submission Details

510(k) Number K193459 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 16, 2019
Decision Date April 27, 2020
Days to Decision 133 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
26d slower than avg
Panel avg: 107d · This submission: 133d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MUJ System, Planning, Radiation Therapy Treatment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MUJ System, Planning, Radiation Therapy Treatment

All 113
Devices cleared under the same product code (MUJ) and FDA review panel - the closest regulatory comparables to K193459.
Syngo.via RT Image Suite
K201444 · Siemens Medical Solutions USA, Inc. · Aug 2020
Eclipse Treatment Planning System v16.1
K201607 · Varian Medical Systems, Inc. · Jul 2020
RayCare 3.1
K200487 · RaySearch Laboratories AB (PUBL) · Jun 2020
ClearCalc
K193640 · Radformation, Inc. · Apr 2020
Eclipse Treatment Planning System v16.0
K200608 · Varian Medical Systems, Inc. · Apr 2020
MRCAT brain
K193109 · Philips Medical Systems MR Finland · Jan 2020